QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 专题：昆明医科大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文 BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2 作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/04 Breast cancer  Multicenter study  PEG-rhG-CSF  Neutropenia   Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial 期刊论文 ONCOTARGETS AND THERAPY, 2018, 卷号: 11 作者:  Wu, Yi-Long;  Xu, Chong-Rui;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun 收藏  |  浏览/下载：16/0  |  提交时间：2019/12/04 afatinib  NSCLC  EGFR  first-line  Phase III  Chinese patients   Gastrodin attenuates microglia activation through renin-angiotensin system and Sirtuin3 pathway 期刊论文 NEUROCHEMISTRY INTERNATIONAL, 2018, 卷号: 120 作者:  Liu, Shun-Jin;  Liu, Xiao-Yu;  Li, Jing-Hui;  Guo, Jing;  Li, Fan 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/04 Activated microglia  Gastrodin  Renin-angiotensin-system  Sirtuin 3  Proinflammatory mediators  Neuroprotection   Symptom and Quality of Life Improvement in LUX-Lung 6 An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 6 作者:  Geater, Sarayut L.;  Xu, Chong-Rui;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/04 Afatinib  Non-small-cell lung cancer  Progression-free survival  Patient-reported outcomes  Quality of life   Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial 期刊论文 LANCET ONCOLOGY, 2014, 卷号: 15, 期号: 2 作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04 LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) versus gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M plus ) advanced adenocarcinoma of the lung. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Wu, Yi Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Ji Feng;  Lu, Shun 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04 LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 期刊论文 EUROPEAN RESPIRATORY JOURNAL, 2013, 卷号: 42 作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/04 Lung cancer / Oncology   Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients 期刊论文 CHINESE MEDICAL JOURNAL, 2013, 卷号: 126, 期号: 12 作者:  Zheng Ying;  Cai Guang-Yan;  Chen Xiang-Mei;  Fu Ping;  Chen Jiang-Hua 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/04 non-dialysis chronic kidney disease  chronic kidney disease stages  hypertension  epidemiology   LUX-Lung 6: Patient-reported outcomes (PROs) from a randomized open-label, phase III study in first-line advanced NSCLC patients (pts) harboring epidermal growth factor receptor (EGFR) mutations 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Geater, Sarayut Lucien;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Ji Feng;  Lu, Shun 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/04 Study on the effect of Catharsis Function of waste residue from extracting pigment of ipamoea batatas L. in mice 期刊论文 Modern Food Science and Technology, 2013, 卷号: 29, 期号: 1 作者:  Qi, De-Li (1);  Wang, Qi (1);  Yin, Jian-Zhong (1);  Shang, Jian-Hua (2);  Xu, Fang (1) 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/04